ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2,2,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
3,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4,1,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
5,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
6,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
7,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
8,1,Headache,Headaches NEC,Headaches,Nerv,N
8,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8,3,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
8,4,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8,5,Migraine,Migraine headaches,Headaches,Nerv,N
8,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9,1,Cardiac assistance device user,Disability issues,Lifestyle issues,SocCi,N
9,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
9,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10,1,Skin candida,Candida infections,Fungal infectious disorders,Infec,N
11,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
12,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
12,2,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
12,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
13,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
14,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
14,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
14,3,Headache,Headaches NEC,Headaches,Nerv,N
15,1,Latent tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
16,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
17,1,Acne,Acnes,Skin appendage conditions,Skin,N
17,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
17,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
18,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
18,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
19,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
20,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
21,1,Decreased interest,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
21,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
21,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
21,4,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
21,5,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
22,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
22,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
22,3,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
22,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
23,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
24,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
25,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
26,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
26,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
27,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
28,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
29,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
29,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
29,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
30,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
31,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
31,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
31,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
31,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
32,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
32,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
33,1,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
33,2,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
33,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
34,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
35,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
35,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
35,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
36,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
37,1,Nasal ulcer,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
38,1,Injection site paraesthesia,Injection site reactions,Administration site reactions,Genrl,N
39,1,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
39,2,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
39,3,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
40,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
41,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
41,2,Gingival disorder,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
42,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
42,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
43,1,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
44,1,Migraine,Migraine headaches,Headaches,Nerv,N
45,1,Dacryocystitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
45,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
45,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
45,4,Periorbital cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
46,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
46,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
47,1,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
47,2,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
48,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
49,1,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
50,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
51,1,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
52,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
53,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
54,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,2,Overweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
54,3,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
55,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
55,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
56,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
57,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
58,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
58,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
59,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
59,2,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
60,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
60,2,Paternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
61,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
61,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
61,3,Dependence on respirator,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
61,4,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
62,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
63,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
63,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
63,3,Chillblains,Conditions caused by cold,Injuries by physical agents,Inj&P,N
63,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
63,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
63,6,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
63,7,Oxygen therapy,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
63,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
63,9,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
64,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
64,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
64,3,Procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
65,1,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
65,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
66,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
66,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
66,3,Chillblains,Conditions caused by cold,Injuries by physical agents,Inj&P,N
66,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
66,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
66,6,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
66,7,Oxygen therapy,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
66,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
66,9,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
67,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
68,1,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
69,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
70,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
70,2,Device defective,Device physical property and chemical issues,Device issues,Prod,N
70,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
70,4,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
70,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
70,6,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
70,7,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
71,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
72,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
73,1,Ectopic pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
74,1,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
75,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
76,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
77,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
78,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
79,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
80,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
81,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
82,1,Acute leukaemia,Leukaemias acute NEC,Leukaemias,Neopl,N
83,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
84,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
85,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
86,1,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
86,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
87,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
88,1,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
88,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
89,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
89,2,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
90,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
91,1,Breast cancer recurrent,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
92,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
92,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
93,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
93,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
94,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
95,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
95,2,Genital rash,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
95,3,Headache,Headaches NEC,Headaches,Nerv,N
95,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
96,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
97,1,Cirrhosis alcoholic,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
97,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
98,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
98,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
98,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
98,4,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
98,5,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
98,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
98,7,Headache,Headaches NEC,Headaches,Nerv,N
98,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
99,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
99,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
99,3,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
99,4,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
99,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
100,1,Bacterial vaginosis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
100,2,Bacterial vaginosis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
101,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
102,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
103,1,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
104,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
105,1,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
106,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
106,2,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
106,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
107,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
108,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
108,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
108,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
108,4,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
108,5,Sputum increased,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
108,6,Sputum purulent,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
108,7,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
109,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
109,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
109,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
110,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
110,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
111,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
112,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
113,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
113,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
114,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
114,2,Seborrhoeic dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
114,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
115,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
116,1,Abscess intestinal,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
116,2,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
116,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
117,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
118,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
119,1,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
120,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
121,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
122,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
123,1,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
124,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
124,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
125,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
125,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
125,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
125,4,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
125,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
126,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
126,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
127,1,Headache,Headaches NEC,Headaches,Nerv,N
128,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
129,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
129,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
130,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
130,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
130,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
130,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
131,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
132,1,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
132,2,Headache,Headaches NEC,Headaches,Nerv,N
132,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
133,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
134,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
135,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
135,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
135,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
136,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
136,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
137,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
137,2,Non-alcoholic fatty liver,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
138,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
139,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
139,2,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
139,3,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
139,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
139,5,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
140,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
141,1,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
142,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
142,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
142,3,Varicose vein,Varicose veins NEC,Venous varices,Vasc,N
143,1,Tinea cruris,Tinea infections,Fungal infectious disorders,Infec,N
144,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
144,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
145,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
146,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
146,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
146,3,Skeletal injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
146,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
147,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
147,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
148,1,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
148,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
149,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
150,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
150,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
151,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
152,1,Pregnancy of partner,Family and partner issues,Family issues,SocCi,N
153,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
153,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
154,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
154,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
155,1,Post inflammatory pigmentation change,Pigmentation changes NEC,Pigmentation disorders,Skin,N
156,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
157,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
158,1,Nonspecific reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
158,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
159,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
159,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
159,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
159,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
159,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
160,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
160,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
160,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
160,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
161,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
162,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
163,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
164,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
165,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
165,2,Headache,Headaches NEC,Headaches,Nerv,N
166,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
166,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
167,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
167,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
167,3,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
168,1,Haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
